Scutebarbatine A is a naturally occurring alkaloid derived from certain plant species, particularly those in the genus *Scutellaria*. It is characterized by its complex molecular structure, which includes multiple rings and functional groups that contribute to its biological activity. This compound has garnered interest in the field of medicinal chemistry due to its potential pharmacological properties, including anti-inflammatory and neuroprotective effects. Scutebarbatine A exhibits a unique mechanism of action, which may involve modulation of neurotransmitter systems or inhibition of specific enzymes. Its solubility and stability can vary depending on the solvent and environmental conditions, making it a subject of study for formulation in drug development. Additionally, research into its biosynthesis and ecological role in the plants that produce it continues to provide insights into its significance in natural product chemistry. Overall, Scutebarbatine A represents a fascinating example of the diverse chemical compounds found in nature and their potential applications in health and medicine.

Scutebarbatine A

Find at CymitQuimica all products linked to CAS 176520-13-1. Enter now to get more information

Scutebarbatine A is a diterpenoid alkaloid, which is derived from the plant *Scutellaria barbata*, a member of the Lamiaceae family. This compound exhibits a complex structure typical of diterpenoid alkaloids and has garnered attention for its pharmacological potential. The mode of action of Scutebarbatine A involves modulation of various neurological pathways, including potential interactions with neurotransmitter systems, which contribute to its neuroprotective effects. Research has indicated that Scutebarbatine A may help in ameliorating oxidative stress and modulating inflammatory responses within neural tissues.

The compound is primarily investigated for its potential applications in neurodegenerative disease research, including conditions like Alzheimer's and Parkinson's disease, where oxidative damage and inflammation are prevalent. It also holds promise as a lead compound for developing new therapeutic agents targeting neurological disorders. Further in-depth studies are essential to fully elucidate the mechanism of action and harness its therapeutic potential.

Scutebarbatine A shows significant antitumor effects on A549 cells in vivo and in vitro via mitochondria-mediated apoptosis by up-regulating expressions of

3-Pyridinecarboxylic acid, 4-[2-(2,5-dihydro-5-oxo-3-furanyl)ethenyl]-1,2,3,4,4a,5,6,8a-octahydro-3-hydroxy-3,4,8,8a-tetramethyl-1,2-naphthalenediyl ester, [1R-[1α,2β,3β,4β(E),4aβ,8aα]]- (9CI)

CAS 176520-13-1: Scutebarbatine A

Scutebarbatine A

Ref: BP-BP3982

Scutebarbatine A

Ref: 3D-BHA52013

Scutebarbatine A

Ref: TM-TN2191

3-Pyridinecarboxylic acid, 4-[2-(2,5-dihydro-5-oxo-3-furanyl)ethenyl]-1,2,3,4,4a,5,6,8a-octahydro-3-hydroxy-3,4,8,8a-tetramethyl-1,2-naphthalenediyl ester, [1R-[1α,2β,3β,4β(E),4aβ,8aα]]- (9CI)

Ref: IN-DA0024Q3